Q3 in line with pre-reported numbers. 2023/24 may be hampered by additional clean-ups. We like the long -term structural growth case, but not at 79x P/E : SELL.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q3 in line with pre-reported numbers. 2023/24 may be hampered by additional clean-ups. We like the long -term structural growth case, but not at 79x P/E : SELL.
